Noxopharm in grant bombshell

Sydney-based Noxopharm is weighing up whether to take legal action against the Department of Industry, Science, Energy and Resources, claiming it was awarded one of the largest grants ever handed out to a biotech for a single drug program - only to be later told the application was in fact unsuccessful, bringing the company to a trading halt on Monday

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here